mesenchymal stem cells/CART cells combination immunotherapy (Apceth/University of Cologne)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemesenchymal stem cells/CART cells combination immunotherapy (Apceth/University of Cologne)
Drug Alias NameN/A
ClassificationBiologics > Antigen > Tumor antigenCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApceth Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApceth Gmbh & Co KgUniversity Of Cologne
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A